Arrowhead Pharmaceuticals Inc. buy HC Wainwright
Start price
13.07.23
/
50%
€30.89
Target price
13.07.24
€80.49
Performance (%)
-24.60%
Price
10.05.24
€20.48
Summary
This prediction is currently active. The price of Arrowhead Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -24.60%. This prediction currently runs until 13.07.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -9.819% | -9.819% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by HC_Wainwright for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by HC_Wainwright for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.61
08.02.24
08.02.24
€83.48
08.02.25
08.02.25
-28.42%
10.05.24
10.05.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.39
10.08.23
10.08.23
€81.59
10.08.24
10.08.24
-22.39%
10.05.24
10.05.24